
Calcitriol (Calcitriol Capsules 0.25 Mcg)
Calcitriol capsule is indicated in the management of secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (Ccr 15…
Calcitriol capsule is indicated in the management of secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (Ccr 15…
PhosLo is indicated for the control of hyperphosphatemia in end stage renal failure and does not promote aluminum absorption. CONTRAINDICATIONS: Patients with hypercalcemia. WARNINGS. Patients with end stage renal failure may develop hypercalcemia…
PhosLo is indicated for the control of hyperphosphatemia in end stage renal failure and does not promote aluminum absorption. CONTRAINDICATIONS: Patients with hypercalcemia. WARNINGS. Patients with end stage renal failure may develop hypercalcemia…
Calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD). Calcium acetate is a phosphate binder indicated for the reduction of serum phosphorus in patients with end stage renal…
Calcium acetate is a phosphate binder indicated to reduce serum phosphorus in patients with end stage renal disease (ESRD). Calcium acetate is a phosphate binder indicated for the reduction of serum phosphorus in patients with end stage renal…
As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.
Terms of Use | Copyright © 2023. All Rights Reserved.